183 related articles for article (PubMed ID: 8422694)
1. Decreased resistance to N,N-dimethylated anthracyclines in multidrug-resistant Friend erythroleukemia cells.
Schaefer A; Westendorf J; Lingelbach K; Schmidt CA; Mihalache DL; Reymann A; Marquardt H
Cancer Chemother Pharmacol; 1993; 31(4):301-7. PubMed ID: 8422694
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H
Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200
[TBL] [Abstract][Full Text] [Related]
3. Reversal of multidrug resistance in Friend leukemia cells by dexniguldipine-HCl.
Reymann A; Looft G; Woermann C; Dietel M; Erttmann R
Cancer Chemother Pharmacol; 1993; 32(1):25-30. PubMed ID: 8462120
[TBL] [Abstract][Full Text] [Related]
4. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A
Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093
[TBL] [Abstract][Full Text] [Related]
5. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
Bogush T; Robert J
Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637
[TBL] [Abstract][Full Text] [Related]
7. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
Mankhetkorn S; Garnier-Suillerot A
Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
[TBL] [Abstract][Full Text] [Related]
8. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
Tapiero H; Nguyen-Ba G; Lampidis TJ
Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
[TBL] [Abstract][Full Text] [Related]
9. N-methylation of anthracyclines modulates their cytotoxicity and pharmacokinetic in wild type and multidrug resistant cells.
Gate L; Couvreur P; Nguyen-Ba G; Tapiero H
Biomed Pharmacother; 2003 Sep; 57(7):301-8. PubMed ID: 14499178
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of four Friend leukemia cell sublines resistant to adriamycin.
Desoize B; Broglio C; Gorisse MC; Briois F; Carpentier Y; Delvincourt C; Dufer J
Anticancer Res; 1994; 14(3A):995-1000. PubMed ID: 8074504
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of amino acid uptake and incorporation into proteins in Friend erythroleukemia cells by the anthracycline antitumor antibiotic aclacinomycin A.
Schaefer A; Boldt J; Westendorf J; Steinheider G; Marquardt H
Biochem Pharmacol; 1988 Apr; 37(7):1377-82. PubMed ID: 3162677
[TBL] [Abstract][Full Text] [Related]
12. [Intracellular accumulation, retention, and distribution of anthracyclines in a multidrug-resistant variant K562r].
Hu X; Chen WY
Zhongguo Yao Li Xue Bao; 1994 May; 15(3):275-9. PubMed ID: 7976387
[TBL] [Abstract][Full Text] [Related]
13. Structurally modified anthracyclines retain activity in a cell line with simultaneous typical and atypical multidrug resistance.
Bielack SS; Kallenbach K; Looft G; Erttmann R; Winkler K
Anticancer Res; 1995; 15(4):1279-84. PubMed ID: 7654009
[TBL] [Abstract][Full Text] [Related]
14. Selection of a new multidrug resistant cell line from Friend leukemia cells by short and cyclic exposures to high concentrations of daunorubicin.
Abbadessa V; Tolomeo M; Luparello M; Perricone R; Cajozzo A; Dusonchet L; Candiloro V; Crosta L; Rausa L
Haematologica; 1992; 77(2):137-41. PubMed ID: 1356894
[TBL] [Abstract][Full Text] [Related]
15. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
Nagasawa K; Natazuka T; Chihara K; Kitazawa F; Tsumura A; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
Cancer Chemother Pharmacol; 1996; 37(4):297-304. PubMed ID: 8548874
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and toxicological aspects of new imidazoacridinone antitumor agents.
Berger B; Marquardt H; Westendorf J
Cancer Res; 1996 May; 56(9):2094-104. PubMed ID: 8616856
[TBL] [Abstract][Full Text] [Related]
18. [Role of cell pharmacokinetics in the modulation of modalities in the administration of anthracyclines].
Tapiéro H; Boule D; Trincal G; Fourcade A
Pathol Biol (Paris); 1987 Jan; 35(1):20-6. PubMed ID: 3550608
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and chemomodulatory effects of interferon-gamma on doxorubicin-sensitive and -resistant tumor cell lines.
Borsellino N; Crescimanno M; Flandina C; Leonardi V; Rausa L; D'Alessandro N
Anticancer Drugs; 1993 Apr; 4(2):265-72. PubMed ID: 8490205
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by novel cyclosporin A analogues and the cyclopeptolide SDZ 214-103 biosynthesized in vitro.
Schwabe K; Steinheider G; Lawen A; Traber R; Hildebrandt A
J Cancer Res Clin Oncol; 1995; 121(7):407-12. PubMed ID: 7635870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
